Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
32.48 USD | -16.56% | -.--% | -26.22% |
05-24 | Japan companies hog the spotlight as hedge funds tout their top Asia picks | RE |
03-31 | A second Kobayashi Pharma Japan factory inspected over deaths | RE |
Sales 2024 * | 177B 1.13B 1.55B | Sales 2025 * | 188B 1.2B 1.65B | Capitalization | 415B 2.64B 3.63B |
---|---|---|---|---|---|
Net income 2024 * | 18.12B 115M 159M | Net income 2025 * | 20.54B 131M 180M | EV / Sales 2024 * | 1.93 x |
Net cash position 2024 * | 72.68B 463M 636M | Net cash position 2025 * | 79.1B 504M 693M | EV / Sales 2025 * | 1.79 x |
P/E ratio 2024 * |
23
x | P/E ratio 2025 * |
20.3
x | Employees | 3,534 |
Yield 2024 * |
1.85% | Yield 2025 * |
1.88% | Free-Float | 59.84% |
1 day | -16.56% | ||
3 months | -26.22% | ||
6 months | -26.22% | ||
Current year | -26.22% |
Managers | Title | Age | Since |
---|---|---|---|
Chairman | 84 | 62-02-28 | |
Noriaki Hirao
DFI | Director of Finance/CFO | - | - |
President | 53 | 98-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Haruo Tsuji
BRD | Director/Board Member | 91 | 08-05-31 |
President | 53 | 98-02-28 | |
Chairman | 84 | 62-02-28 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.37% | 394B | |
+17.86% | 77.03B | |
-3.72% | 72.5B | |
-18.02% | 43.2B | |
-14.81% | 35.21B | |
+6.23% | 35.09B | |
+11.60% | 18.89B | |
+25.80% | 17.49B | |
+11.24% | 13.01B |
- Stock Market
- Equities
- 4967 Stock
- KBYPF Stock